Colorado is making a play for a Japanese CDMO in hopes it will invest about $100 million in an empty AstraZeneca plant in Boulder. It just isn’t saying who it is.
Development officials have put together a package of about $6.5 million in tax incentives for what it has code-named Project Blizzard. The Colorado Daily reports there are inferences the CDMO is AGC Biologics. Documents indicated the CDMO would invest about $100 million in the facility and create 280 new jobs.